CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,000 | -93.8% | 10,596 | -82.9% | 0.00% | – |
| Q2 2021 | $113,000 | +109.3% | 61,837 | +126.8% | 0.00% | – |
| Q1 2021 | $54,000 | +54.3% | 27,262 | -1.9% | 0.00% | – |
| Q4 2020 | $35,000 | -75.4% | 27,791 | -64.7% | 0.00% | – |
| Q3 2020 | $142,000 | -84.4% | 78,719 | -27.3% | 0.00% | -100.0% |
| Q2 2020 | $909,000 | +178.0% | 108,299 | +73.8% | 0.00% | – |
| Q1 2020 | $327,000 | +138.7% | 62,310 | +147.8% | 0.00% | – |
| Q4 2019 | $137,000 | +77.9% | 25,148 | +59.8% | 0.00% | – |
| Q3 2019 | $77,000 | -37.4% | 15,736 | -11.4% | 0.00% | – |
| Q2 2019 | $123,000 | – | 17,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |